SOURCE: American Diabetes Association

American Diabetes Association

May 24, 2011 11:43 ET

American Diabetes Association Announces New Research Grant for Diabetes Technology

Medtronic Commits Funding to Examine the Impact of Technology-Based Diabetes Management Tools on Clinical Outcomes

ALEXANDRIA, VA--(Marketwire - May 24, 2011) - The American Diabetes Association announced today new research funding to study the effectiveness of technology-based diabetes management devices. The research awards will be granted pursuant to an application process and supported by Medtronic.

Studies funded by the American Diabetes Association/Medtronic Technology in Diabetes Fellowship will utilize Medtronic's CareLink database -- a database of anonymous continuous glucose monitoring and insulin pump-derived data -- to assess, evaluate, and correlate the application of this and similar technologies used by patients with insulin-treated diabetes. Research will examine the impact of diabetes management tools on clinical outcomes, compliance and use of diabetes devices as well as various factors that affect glycemic control in patients with diabetes.

The CareLink database is a secure online database that contains anonymous data downloaded from diabetes management devices. The use of CareLink in conjunction with continuous glucose monitoring systems provides immediate electronic access to data for people with diabetes, providing both patients and healthcare providers with the ability to optimize diabetes therapy. Researchers will be provided with aggregated data from more than 200,000 individuals with diabetes, some of those with multiple years of continuous information. All data provided to researchers will be completely anonymous and HIPAA compliant.

"Research like this will help us better understand patient behavior," commented Robert R. Henry, MD, President, Medicine & Science, American Diabetes Association. "In the long run, this research can help influence future diabetes technology and shape how we educate people with diabetes."

"Making this anonymous information available to scientists gives them the opportunity to garner a better understanding of how patients manage their diabetes on a daily basis, which we hope will impact both how clinicians guide their patients and how industry develops products to better meet the needs of people with diabetes," said Dr. Francine Kaufman, Chief Medical Officer for Medtronic and former president of the American Diabetes Association (2002-2003).

Some examples of research areas that could be supported by this initiative include questions relevant to glycemic variability, insulin dosing and dose timing, hypoglycemic event prediction and patient outcomes and response to technology.

The American Diabetes Association/Medtronic Technology in Diabetes Fellowship application deadline is August 15, 2011. Recipients will be notified no later than December 2011. Successful applications will receive up to a maximum of $17,500 over a term of one year. Clinical and post-doctoral fellows and scientists-in-training are encouraged to apply. The American Diabetes Association expects to be able to fund 2-3 meritorious applications. The request for application (RFA) can be found at http://professional.diabetes.org.

About American Diabetes Association

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

About the Diabetes Business at Medtronic
The Diabetes business at Medtronic (www.medtronicdiabetes.com and www.medtronic-diabetes.co.uk) is the world leader in diabetes management. The product line of the Diabetes business includes insulin pump therapy, continuous glucose monitoring systems, related disposable products and diabetes management software.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology -- alleviating pain, restoring health and extending life for millions of people around the world.

Contact Information

  • Contact:
    Christine Feheley
    703-253-4374
    Amanda Sheldon
    818-576-4826

Webosphere

Keyword Cloud

View Website